{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:15Z","timestamp":1789771455241,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.mycmed.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T04:46:34Z","timestamp":1383799594000},"page":"270-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia"],"prefix":"10.1016","volume":"23","author":[{"given":"C.","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Thyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gari-Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2013.10.001_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10156-010-0028-X","article-title":"Ocular and cerebral aspergillosis in a non-neutropenic patient following alemtuzumab and methyl prednisolone treatment for chronic lymphocytic leukaemia","volume":"16","author":"Anoop","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0010","first-page":"19","article-title":"Alemtuzumab use in relapsed and refractory chronic lymphocytic lymphoma","volume":"1","author":"Arnason","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0195-6701(89)90110-2","article-title":"Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation","volume":"14","author":"Barnes","year":"1989","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/501661","article-title":"Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against aspergillus airborne contamination during hospital renovation","volume":"20","author":"Cornet","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2141.2011.08965.x","article-title":"An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed\/refractory chronic lymphocytic leukaemia patients on behalf of the GIMEMA chronic lymphoproliferative disorders working party","volume":"156","author":"Cortelezzi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0030","first-page":"364","article-title":"Alemtuzumab: what is the secret to safe therapy?","volume":"9","author":"Elter","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1007116523000","article-title":"Concomitant renal and prostatic aspergillosis","volume":"31","author":"Hemal","year":"1999","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2011.08570.x","article-title":"Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia","volume":"153","author":"Karia","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3109\/10428194.2012.659735","article-title":"Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian lymphoma study group","volume":"53","author":"Kim","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0050","first-page":"1248","article-title":"Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir","volume":"89","author":"Laurenti","year":"2004","journal-title":"Haematol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/504811","article-title":"Infectious complications associated with alemtuzumab use for lymphoproliferative disorders","volume":"43","author":"Martin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood.V110.11.756.756","article-title":"Alemtuzumab increases serious infections in patients with previously untreated chronic lymphocytic leukemia (CLL) receiving fludarabine-based therapy: a comparative analysis of 3 cancer and leukemia Group B Studies (CALGB 9011, 9712, 19901)","volume":"110","author":"Morrison","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.1054","article-title":"Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemo-prophylaxis and institution of HEPA filters","volume":"66","author":"Oren","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0002-9343(87)90902-8","article-title":"Impact of air filtration on nosocomial aspergillus infections. Unique risk of bone marrow transplant recipients","volume":"83","author":"Sherertz","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.mycmed.2013.10.001_bib0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523313001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523313001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:16:00Z","timestamp":1761110160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523313001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1156523313001650"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2013.10.001","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostatic and renal aspergillosis due to Aspergillus fumigatus in a patient receiving alemtuzumab for chronic lymphocytic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}